Advances in the treatment of blood disorders.
D000741:Anemia, Aplastic / Q000628:therapy; D000747:Anemia, Hypochromic / Q000188:drug therapy; D000748:Anemia, Macrocytic / Q000188:drug therapy; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000628:therapy*; D006801:Humans; D006879:Hydroxocobalamin / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007501:Iron / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D011087:Polycythemia Vera / Q000532:radiotherapy; D011247:Pregnancy; D011696:Purpura, Thrombocytopenic / Q000628:therapy; D013927:Thrombosis / Q000188:drug therapy
D000888:Antibodies, Anti-Idiotypic; D000970:Antineoplastic Agents; D005492:Folic Acid; D007501:Iron; D006879:Hydroxocobalamin